SHR-A1811, a novel anti-HER2 antibody-drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles
SHR-A1811 是一种新型抗 HER2 抗体药物偶联物，具有最佳的药物抗体比、高效的肿瘤杀伤效力和良好的安全性。
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0326691
Zhang, Ting; Xu, Jianyan; Yin, Junzhao; Gao, Yun; Zheng, Hanwen; Fu, Beibei; Sun, Jiakang; Xu, Zhibin; Tu, Shiwei; Mao, Yuchang; Wen, Weiyun; Qu, Bolei; You, Lingfeng; Xue, Zhendong; Sun, Xing; Cao, Dan; Feng, Jun; Hu, Min; He, Feng
